Moderna Ownership | Who Owns Moderna?
Moderna Ownership Summary
Moderna is owned by 1.65% institutional investors, 7.28% insiders, and 91.07% retail investors. Vanguard group is the largest institutional shareholder, holding 10.47% of MRNA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.88% of its assets in Moderna shares.
MRNA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Moderna | 1.65% | 7.28% | 91.07% |
| Sector | Healthcare Stocks | 278.70% | 10.61% | -189.31% |
| Industry | Biotech Stocks | 63.84% | 10.66% | 25.50% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vanguard group | 40.32M | 10.47% | $1.68B |
| Baillie gifford | 38.89M | 10.10% | $1.62B |
| Blackrock funding, inc. /de | 25.79M | 6.70% | $1.07B |
| Fmr | 18.66M | 4.85% | $776.08M |
| Theleme partners llp | 7.31M | 1.90% | $303.82M |
| Geode capital management | 7.24M | 1.88% | $300.22M |
| Ubs group | 5.07M | 1.32% | $210.95M |
| Invesco | 5.01M | 1.30% | $208.17M |
| Flagship pioneering | 4.63M | 1.20% | $131.32M |
| Norges bank | 3.94M | 1.02% | $163.83M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Flagship pioneering | 4.63M | 55.70% | $131.32M |
| Merck | 2.31M | 37.19% | $95.97M |
| Theleme partners llp | 7.31M | 20.36% | $303.82M |
| Washington university | 150.00K | 5.31% | $6.24M |
| Intrinsic value partners | 36.26K | 1.51% | $1.51M |
| Bellevue group | 1.60M | 1.28% | $66.56M |
| Baillie gifford | 38.89M | 1.24% | $1.62B |
| Quattro financial advisors | 84.60K | 0.89% | $3.44M |
| Banque pictet & cie sa | 3.13M | 0.87% | $130.27M |
| Tang capital management | 300.00K | 0.83% | $12.47M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Norges bank | 3.94M | 0.02% | 3.94M |
| Jane street group | 3.62M | 0.03% | 2.98M |
| Ubs group | 5.07M | 0.04% | 2.80M |
| Merck | 2.31M | 37.19% | 2.31M |
| Voloridge investment management | 2.59M | 0.38% | 2.00M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Baillie gifford | 38.89M | 1.24% | -3.57M |
| Mawer investment management | - | - | -1.90M |
| Jpmorgan chase | 523.18K | 0.00% | -1.70M |
| Wellington management group llp | 3.92M | 0.03% | -1.31M |
| Ark investment management | - | - | -1.16M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 3.94M | 0.02% | 3.94M | $163.83M |
| Merck | 2.31M | 37.19% | 2.31M | $95.97M |
| Sessa capital im | 743.08K | 0.82% | 743.08K | $21.07M |
| Grantham, mayo, van otterloo | 547.81K | 0.07% | 547.81K | $22.78M |
| Hudson bay capital management lp | 500.02K | 0.07% | 500.02K | $20.79M |
Sold Out
| Holder | Change |
|---|---|
| Lam group | -1.00 |
| Hollencrest capital management | -1.00 |
| Mendota financial group | -1.00 |
| Thompson investment management | -2.00 |
| Voisard asset management group | -5.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 16 | -98.03% | 6,386,850 | -97.69% | 1 | 0.03% | 6 | -98.36% | 3 | -98.87% |
| Dec 31, 2024 | 727 | -15.17% | 255,844,003 | -0.71% | 66 | 1.48% | 324 | 0.31% | 242 | -24.38% |
| Sep 30, 2024 | 853 | -17.02% | 257,576,845 | -1.79% | 66 | 1.42% | 321 | -31.41% | 319 | 5.28% |
| Jun 30, 2024 | 1,028 | 6.09% | 262,270,346 | 1.07% | 68 | 1.49% | 468 | 6.61% | 303 | 1.68% |
| Mar 31, 2024 | 969 | 1.89% | 259,490,653 | 0.92% | 67 | 1.50% | 439 | 6.30% | 298 | -11.31% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 11.15M | 2.88% | 7.56K |
| Vanguard US Total Market Shares ETF | 10.99M | 2.85% | 80.25K |
| Vanguard Institutional 500 Index Trust | 9.62M | 2.49% | 60.72K |
| Scottish Mortgage Ord | 8.63M | 2.23% | - |
| Invesco QQQ Trust | 7.63M | 1.98% | - |
| Fidelity Growth Compy Commingled Pl S | 6.79M | 1.76% | 5.03K |
| Vanguard International Growth Inv | 6.40M | 1.66% | - |
| Invesco S&P 500® Equal Weight ETF | 5.15M | 1.33% | 60.50K |
| Fidelity Growth Company Fund | 4.92M | 1.27% | 12.99K |
| Vanguard Small Cap Index | 4.38M | 1.13% | 21.49K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jun 11, 2025 | Hussain Abbas | - | Sell | $8.74K |
| Mar 03, 2025 | Bancel Stephane | Chief Executive Officer | Buy | $1.81M |
| Mar 03, 2025 | Bancel Stephane | Chief Executive Officer | Buy | $3.19M |
| Mar 03, 2025 | SAGAN PAUL | - | Buy | $1.00M |
| Dec 09, 2024 | Klinger Shannon Thyme | Chief Legal Officer | Sell | $23.64K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | - | 1 |
| 2025 Q1 | 3 | - |
| 2024 Q4 | - | 8 |
| 2024 Q3 | - | 29 |
| 2024 Q2 | - | 108 |
MRNA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools